1. "Alumni (GSK)"
Formats
  1. Journal Article (683)
  2. Meeting Abstract (233)
  3. Review (19)
  4. Editorial (13)
  5. Research Letter (8)
  6. Book Section (2)
  7. Correspondence (2)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Alumni (GSK) (962)
  2. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (962)
  3. GSK Faculty (850)
  4. Sloan Kettering Institute Postdocs (677)
  5. Sloan Kettering Institute Faculty (556)
  6. MSK Grad Students (525)

More Groups

People
  1. Ross Levine (119)
  2. Michael Berger (52)
  3. Robert Bowman (51)
  4. Semanti Mukherjee (50)
  5. David Solit (49)
  6. Elisa De Stanchina (47)

More People

Years
  1. 2025 (9)
  2. 2024 (55)
  3. 2023 (75)
  4. 2022 (100)
  5. 2021 (75)
  6. 2020 (91)

More Years

Publications
  1. Blood (73)
  2. Cancer Research (67)
  3. Nature (42)
  4. Nature Communications (33)
  5. Cancer Discovery (30)
  6. Cell Reports (30)

More Publications

Publishers
  1. Nature Publishing Group (177)
  2. Cell Press (151)
  3. American Association for Cancer Research (130)
  4. American Society of Hematology (74)
  5. American Society of Clinical Oncology (31)
  6. American Association for the Advancement of Science (27)

More Publishers

Results (962)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
    Journal Article

    Dikiy, S.; Ghelani, A. P.; Levine, A. G.; Martis, S.; Giovanelli, P.; Wang, Z. M.; Beroshvili, G.; Pritykin, Y.; Krishna, C.; Huang, X.; more...
    Nature Immunology (2025)

    Fulltext@MSK | Save
  • Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
    Journal Article

    Boehm, K. M.; El Nahhas, O. S. M.; Marra, A.; Waters, M.; Jee, J.; Braunstein, L.; Schultz, N.; Selenica, P.; Wen, H. Y.; Weigelt, B.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Germline UBA1 variant with somatic amplification in a woman with inflammatory diseases and myelodysplastic syndrome
    Journal Article

    Creignou, M.; Sirenko, M.; Moura, P. L.; Mortera-Blanco, T.; Dimitriou, M.; Sander, B.; Domenico, D.; Arango Ossa, J. E.; Tesi, B.; Beck, D. B.; more...
    Annals of Internal Medicine (2025)

    Fulltext@MSK | Save
  • Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Journal Article

    Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
    Science Advances (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity
    Journal Article

    Raeisi Dehkordi, S.; Wong, I. T. L.; Ni, J.; Luebeck, J.; Zhu, K.; Prasad, G.; Krockenberger, L.; Xu, G.; Chowdhury, B.; Rajkumar, U.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • The evolutionary forest of pancreatic cancer
    Journal Article

    Mullen, K. M.; Hong, J.; Attiyeh, M. A.; Hayashi, A.; Sakamoto, H.; Kohutek, Z. A.; McIntyre, C. A.; Zhang, H.; Makohon-Moore, A. P.; Zucker, A.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Simplifying clinical use of TCGA molecular subtypes through machine learning models
    Editorial

    Boehm, K. M.; Sánchez-Vega, F.
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Chromothripsis-mediated small cell lung carcinoma
    Journal Article

    Rekhtman, N.; Tischfield, S. E.; Febres-Aldana, C. A.; Lee, J. J. K.; Chang, J. C.; Herzberg, B. O.; Selenica, P.; Woo, H. J.; Vanderbilt, C. M.; Yang, S. R.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • SAABR: Single arm phase II study of androgen receptor pathway inhibitor (ARPI) + atezolizumab + GnRH analog (ADT) and stereotactic body radiotherapy (SBRT) to the prostate in men with de novo hormone-sensitive metastatic prostate cancer (mHSPC)
    Meeting Abstract

    Rathkopf, D.; Dallos, M.; Stein, M.; Spina, C. S.; Deutsch, I.; Nguyen, C.; Okada, A.; Lloyd, M.; Manarite, J.; McBride, S.
    Annals of Oncology (2024)

    Fulltext@MSK | Save